✦ LIBER ✦

211 Phase III Trial (EORTC 10801) Comparing Breast-conserving Therapy with Radical Mastectomy – Twenty Year Follow-up Results

✍ Scribed by S. Litière; G. Werutsky; I.S. Fentiman; E. Rutgers; M.R. Christiaens; E. Van Limbergen; M.H.A. Baaijens; J. Bogaerts; H. Bartelink

Book ID: 117662121
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 73 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)70279-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast conserving therapy versus mastect

Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

✍ Saskia Litière; Gustavo Werutsky; Ian S Fentiman; Emiel Rutgers; Marie-Rose Chri 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 327 KB

Twenty-Year Follow-up of a Randomized St

Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer

✍ Veronesi, Umberto; Cascinelli, Natale; Mariani, Luigi; Greco, Marco; Saccozzi, R 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 152 KB

Sixteen years follow-up results of a ran

Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience

✍ Leone, JosÃ© Pablo; Leone, Julieta; Vallejo, Carlos Teodoro; PÃ©rez, Juan Eduard 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 359 KB